New CEO Zikria Unveils 30-Day Value Creation Agenda
Interim CEO Dean Zikria prioritizes advancing Entolimod, pursuing commercial capabilities at CDMO Velocity, and evaluating strategic deals to address undervaluation.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed